Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 05, 2021

SELL
$2.91 - $4.83 $1,134 - $1,883
-390 Closed
0 $0
Q2 2021

Aug 06, 2021

SELL
$4.17 - $5.74 $10,475 - $14,418
-2,512 Reduced 86.56%
390 $1,000
Q1 2021

May 07, 2021

BUY
$5.28 - $9.64 $31 - $57
6 Added 0.21%
2,902 $15,000
Q4 2020

Feb 12, 2021

SELL
$5.75 - $7.13 $1,702 - $2,110
-296 Reduced 9.27%
2,896 $18,000
Q3 2020

Nov 06, 2020

SELL
$4.9 - $7.12 $2,067 - $3,004
-422 Reduced 11.68%
3,192 $19,000
Q2 2020

Aug 07, 2020

SELL
$6.43 - $9.86 $7,285 - $11,171
-1,133 Reduced 23.87%
3,614 $26,000
Q1 2020

May 08, 2020

BUY
$6.36 - $10.05 $1,011 - $1,597
159 Added 3.47%
4,747 $32,000
Q4 2019

Feb 07, 2020

BUY
$8.49 - $12.81 $3,277 - $4,944
386 Added 9.19%
4,588 $40,000
Q3 2019

Nov 08, 2019

BUY
$5.58 - $14.47 $915 - $2,373
164 Added 4.06%
4,202 $47,000
Q2 2019

Aug 09, 2019

SELL
$5.22 - $9.08 $172 - $299
-33 Reduced 0.81%
4,038 $0
Q1 2019

May 10, 2019

SELL
$5.35 - $9.82 $743 - $1,364
-139 Reduced 3.3%
4,071 $0
Q4 2018

Feb 08, 2019

BUY
$3.43 - $6.19 $9,367 - $16,904
2,731 Added 184.65%
4,210 $20,000
Q3 2018

Nov 09, 2018

SELL
$4.75 - $14.5 $1,016 - $3,103
-214 Reduced 12.64%
1,479 $0
Q2 2018

Aug 10, 2018

SELL
$13.3 - $17.45 $4,202 - $5,514
-316 Reduced 15.73%
1,693 $0
Q1 2018

May 11, 2018

BUY
$14.7 - $24.95 $9,599 - $16,292
653 Added 48.16%
2,009 $0
Q4 2017

Feb 09, 2018

BUY
$19.9 - $29.25 $2,109 - $3,100
106 Added 8.48%
1,356 $0
Q3 2017

Nov 13, 2017

BUY
$15.1 - $19.25 $18,875 - $24,062
1,250
1,250 $0

Others Institutions Holding LCI

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About LANNETT CO INC


  • Ticker LCI
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 42,960,000
  • Market Cap $1.29M
  • Description
  • Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...
More about LCI
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.